Sawada, Akihisa <br/><br/>
Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia.  [electronic resource] 

 -  Leukemia research  Dec 2009 
 - 1710-3 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2009.06.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--blood<br/>Child<br/>Child, Preschool<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Infant<br/>Male<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--blood<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Treatment Outcome